Omega Therapeutics Inc (OMGA) — Financial Flexibility Index
Omega Therapeutics Inc (OMGA) has a Financial Flexibility Index of -0.10x as of September 2024. Free cash flow of $-14.00 Million (operating CF $-14.02 Million minus capex $16.00K) represents 0% of total liabilities ($141.18 Million). Check Omega Therapeutics Inc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Omega Therapeutics Inc Financial Flexibility Index (2019–2023)
Historical Financial Flexibility Index trend for Omega Therapeutics Inc across 5 annual periods. See OMGA current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Omega Therapeutics Inc (2019–2023)
Year-by-year free cash flow to debt coverage for Omega Therapeutics Inc. For the full company profile including market capitalisation, see OMGA market cap.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2023 | -0.61x | $-88.64 Million | $-91.51 Million | $146.35 Million | ▲ +75.0% |
| 2022 | -2.43x | $-97.14 Million | $-98.52 Million | $40.03 Million | ▼ -41.4% |
| 2021 | -1.72x | $-56.14 Million | $-57.61 Million | $32.70 Million | ▼ -554.3% |
| 2020 | -0.26x | $-24.32 Million | $-26.13 Million | $92.71 Million | ▲ +25.4% |
| 2019 | -0.35x | $-14.79 Million | $-15.68 Million | $42.04 Million | — |